NRAW have a look at the revenue growth of AVH it is basically a year behind PNV...... Management expects revenue of around $78,000,000 and cashflow break even by second quarter 2025. Combining the two makes heaps of sense and synergies as both have large USA based sales forces.
Time will tell i just wanted to let people know and have a look at AVH, I've done very well out of PNV and learned loads from some clever PNV posters so wanted to pay a bit back.
The increase in joint studies of BTM and Recall will only get more and more in my opinion and the AVH share price is very attractive coming from a PNV script prospective and both have nil debt
- Forums
- ASX - By Stock
- PNV
- The Clinicians Speak
The Clinicians Speak, page-1012
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Is oil undervalued?
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.43 |
Change
0.110(4.74%) |
Mkt cap ! $1.677B |
Open | High | Low | Value | Volume |
$2.39 | $2.45 | $2.38 | $2.896M | 1.198M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | $2.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.43 | 9997 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 2.410 |
4 | 6418 | 2.400 |
6 | 22405 | 2.390 |
4 | 14128 | 2.380 |
1 | 2656 | 2.370 |
Price($) | Vol. | No. |
---|---|---|
2.430 | 9997 | 4 |
2.440 | 53091 | 5 |
2.450 | 29382 | 6 |
2.460 | 5156 | 2 |
2.470 | 22772 | 5 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
PNV (ASX) Chart |